Bangalore: Sanofi Pasteur, the vaccines division of Sanofi, will provide 1.7 billion doses of oral polio vaccine (OPV) t...
Singapore: Clinical-stage Dutch biotechnology company, Mucosis has entered into a long-term collaboration and license ag...
Singapore: South Korea-headquartered International Vaccine Institute (IVI) has appointed Professor Fred Binka, Dr Josep...
Bangalore: Bharat Biotech and The University of Maryland Center for Vaccine Development have received a $4 million strat...
Singapore: Saudi health officials declared that they had finally discovered new antibodies to combat the MERS virus. The...
Singapore: Tokyo-headquartered Eisai has signed a global agreement with Brazil's Fundação Oswaldo Cruz for collabo...
Singapore: Marking the start of the World Immunization Week, the Hilleman Laboratories, an equal joint-venture partnersh...
Singapore: Influenza vaccine (gH1-Qbeta) developed by Singapore's Agency for Science, Technology and Research (A*STAR) a...
Hyderabad: Dr Vijay Kumar Datla, chairman and managing director of Biological E, will be given FABA Special Award 2013 ...
During March 2013, the world woke up to yet another dreaded bird flu attack that infected humans through poultry. Two mo...
Singapore: Researchers at the Burnet Institute have solved a hepatitis C vaccine mystery which, once developed, could b...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem is developing an antimicrobial ...
A better flu drug is on its way. This new class of specific, mechanism-based anti-influenza drug works by preventing the...
Singapore: Medicago has granted Philip Morris Products (PMP) an exclusive license to develop, commercialize and manufact...
Singapore: Japanese company, Takeda Pharmaceutical is looking to acquire Inviragen for an upfront payment of $35 million...
Allied Healthcare Group's investment company, Coridon, which is led by Professor Ian Frazer, is in the process of develo...
Singapore: Duke University has received a grant of up to $2.9 million from the Bill & Melinda Gates Foundation to pr...
Singapore: Following successful first-in-man phase I and two phase IIa clinical studies with the oral formulation of fin...
